XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common shares and paid-in surplus
Retained earnings
AOCI, after tax
Total
Non-controlling interest
Total Equity
Foreign Currency Gain (Loss)
Common shares and paid-in surplus
Foreign Currency Gain (Loss)
Retained earnings
Foreign Currency Gain (Loss)
AOCI, after tax
Foreign Currency Gain (Loss)
Total
Foreign Currency Gain (Loss)
Non-controlling interest
Foreign Currency Gain (Loss)
Total Equity
OneBeacon
Common shares and paid-in surplus
OneBeacon
Retained earnings
OneBeacon
AOCI, after tax
OneBeacon
Total
OneBeacon
Non-controlling interest
OneBeacon
Total Equity
Sale of Tranzact
Common shares and paid-in surplus
Sale of Tranzact
Retained earnings
Sale of Tranzact
AOCI, after tax
Sale of Tranzact
Total
Sale of Tranzact
Non-controlling interest
Sale of Tranzact
Total Equity
Beginning Balances at Dec. 31, 2016   $ 810.7 $ 2,776.6 $ (4.6) $ 3,582.7 $ 133.3 $ 3,716.0                                    
Increase (Decrease) in Shareholders' Equity                                                  
Net loss (income) $ 28.0 0.0 29.0 0.0 29.0 (1.0) 28.0                                    
Net change in foreign currency translation and benefit plan assets and obligations               $ 0.0 $ 0.0 $ 0.2 $ 0.2 $ 0.0 $ 0.2                        
Total comprehensive income (loss) 29.2 0.0 29.0 0.2 29.2 (1.0) 28.2                                    
Dividends declared on common shares   0.0 (4.6) 0.0 (4.6) 0.0 (4.6)                                    
Dividends to non-controlling interests   0.0 0.0 0.0 0.0 (6.6) (6.6)                                    
Repurchases and retirements of common shares   (1.4) (5.1) 0.0 (6.5) (1.1) (7.6)                                    
Dilution from equity-based units of subsidiary                           $ (4.1) $ 0.0 $ 0.0 $ (4.1) $ 4.1 $ 0.0            
Capital contributions from BAM members, net of tax (9.6) 0.0 0.0 0.0 0.0 7.0 7.0                                    
Amortization of restricted share awards   2.6 0.0 0.0 2.6 0.2 2.8                                    
Deconsolidation of non-controlling interests associated with the sale of Tranzact                                       $ 0.0 $ 0.0 $ 0.0 $ 0.0 $ (4.4) $ (4.4)
Ending Balances at Mar. 31, 2017 3,730.8 807.8 2,795.9 (4.4) 3,599.3 131.5 3,730.8                                    
Beginning Balances at Dec. 31, 2016   810.7 2,776.6 (4.6) 3,582.7 133.3 3,716.0                                    
Increase (Decrease) in Shareholders' Equity                                                  
Recognition of equity-based units of subsidiary           (2.3) (6.4)                                    
Dilution from equity-based units of subsidiary           0.9 0.0                                    
Ending Balances at Dec. 31, 2017 3,360.8 670.6 2,823.2 (1.3) 3,492.5 (131.7) 3,360.8                                    
Increase (Decrease) in Shareholders' Equity                                                  
Net loss (income) (66.6) 0.0 (48.0) 0.0 (48.0) (18.6) (66.6)                                    
Net change in foreign currency translation and benefit plan assets and obligations               $ 0.0 $ 0.0 $ 0.0 $ 0.0 $ 0.0 $ 0.0                        
Total comprehensive income (loss) (48.0) 0.0 (48.0) 0.0 (48.0) (18.6) (66.6)                                    
Dividends declared on common shares   0.0 (3.8) 0.0 (3.8) 0.0 (3.8)                                    
Dividends to non-controlling interests   0.0 0.0 0.0 0.0 (0.3) (0.3)                                    
Repurchases and retirements of common shares   (1.9) (6.4) 0.0 (8.3) 0.0 (8.3)                                    
Recognition of equity-based units of subsidiary   (4.1) 0.0 0.0 (4.1)                                        
Dilution from equity-based units of subsidiary   (0.9) 0.0 0.0 (0.9)                                        
Capital contributions from BAM members, net of tax (4.9) 0.0 0.0 0.0 0.0 4.2 4.2                                    
Amortization of restricted share awards   3.4 0.0 0.0 3.4 0.0 3.4                                    
Ending Balances at Mar. 31, 2018 $ 3,295.8 $ 675.3 $ 2,765.0 $ (1.3) $ 3,439.0 $ (143.2) $ 3,295.8